Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Steatorrhea
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Causes== Impaired digestion or absorption can result in fatty stools. Possible causes include [[exocrine pancreatic insufficiency]], with poor digestion from lack of [[lipases]], loss of [[bile salts]], which reduces [[micelle]] formation, and small intestinal disease-producing [[malabsorption]]. Various other causes include certain medicines that block fat absorption or indigestible or excess oil/fat in diet.<ref name="StatPearls"/> The absence of [[bile]] secretion can cause the feces to turn gray or pale. Bile is responsible for the brownish color of feces. In addition to this, bile also plays a role in fat absorption, where dietary lipids are combined so that pancreatic lipases can hydrolyze them before going towards the small intestine. Without bile acids, this pathway would have a hard time occurring, which would lead to fat malabsorption and make steatorrhea more probable to occur.<ref name="StatPearls"/> Other features of fat malabsorption may also occur such as reduced bone density, difficulty with vision under low light levels, bleeding, bruising, and slow blood clotting times.<ref name="Handbook"/> ===Associated diseases=== * Conditions affecting the [[pancreas]]. [[Exocrine pancreatic insufficiency]]<ref name="pmid24259956">{{cite journal |vauthors=Lindkvist B |title=Diagnosis and treatment of pancreatic exocrine insufficiency |journal=World J. Gastroenterol. |volume=19 |issue=42 |pages=7258β66 |year=2013 |pmid=24259956 |pmc=3831207 |doi=10.3748/wjg.v19.i42.7258 |type=Review |doi-access=free }}</ref> can be caused by chronic [[pancreatitis]], [[cystic fibrosis]] and [[pancreatic cancer]] (if it obstructs biliary outflow).<ref name="Handbook"/> * Conditions affecting [[bile salts]]. Obstruction of the [[bile ducts]] by [[gallstones]] ([[choledocholithiasis]]), [[primary sclerosing cholangitis]], [[liver damage]] ([[hepatitis]], intrahepatic [[cholestasis]]), [[hypolipidemic]] drugs, or changes following [[gallbladder]] removal ([[cholecystectomy]]).<ref name="Handbook"/> * Conditions producing intestinal [[malabsorption]]. These include [[celiac disease]], [[bacterial overgrowth]], [[tropical sprue]], [[giardiasis]] (a protozoan parasite infection), [[Zollinger-Ellison syndrome]], [[short bowel syndrome]], [[inflammatory bowel disease]] and [[abetalipoproteinemia]].<ref name="Handbook"/><ref name="pmid20626336">{{cite journal |last1=Moutzouri |first1=Elisavet |last2=Elisaf |first2=Moses |last3=Liberopoulos |first3=N. Evangelos |year=2011 |title=Hypocholesterolemia |journal=Current Vascular Pharmacology |volume=9 |issue=2 |pages=200β12 |doi=10.2174/157016111794519354 |pmid=20626336}}</ref> * Other causes: Drugs that can produce steatorrhea include [[orlistat]], a slimming pill, or as adverse effect of [[octreotide]] or [[lanreotide]], used to treat [[acromegaly]] or other [[neuroendocrine tumors]].<ref>{{cite journal|last1=Dogliotti|first1=L|last2=Tampellini|first2=M|last3=Stivanello|first3=M|last4=Gorzegno|first4=G|last5=Fabiani|first5=L|title=The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy|journal=Annals of Oncology|date=2001|volume=12|issue=Suppl 2|pages=S105β9|pmid=11762334|doi=10.1093/annonc/12.suppl_2.s105|doi-access=}}</ref> It can be found in [[Graves' disease]] / [[hyperthyroidism]].<ref name="Handbook"/> ===Medications=== [[Orlistat]] (also known by trade names Xenical and Alli) is a diet pill that works by blocking [[Lipase|the enzymes that digest fat]]. As a result, some fat cannot be absorbed from the gut and is excreted in the feces instead of being metabolically digested and absorbed, sometimes causing oily anal leakage.<ref name=WP>{{cite news |first= Sally|last= Squires|title=Weighing a Pill For Weight Loss |url=https://www.washingtonpost.com/wp-dyn/content/article/2006/01/23/AR2006012301270.html |quote=While the Food and Drug Administration (FDA) still must approve the switch, the agency often follows the advice of its experts. If it does, Orlistat (xenical) -- currently sold only by prescription -- could be available over-the-counter (OTC) later this year. But it's important to know that the weight loss that's typical for users of the drug -- 5 to 10 percent of total weight -- will be less than many dieters expect. And many consumers may be put off by the drug's significant gastrointestinal side effects, including [[flatulence]], [[diarrhea]], and anal leakage. |newspaper=[[Washington Post]] |date= 2006-01-24|access-date=2007-07-06}}</ref><ref name=CSPI>{{cite news |title=Frito-Lay Study: Olestra Causes "Anal Oil Leakage" |url=http://www.cspinet.org/new/flaynal.html |quote=The Frito-Lay report states: "The anal oil leakage symptoms were observed in this study (3 to 9% incidence range above background), as well as other changes in elimination. ... Underwear spotting was statistically significant in one of two low-level consumer groups at a 5% incidence above background." Despite those problems, the authors of the report concluded that olestra-containing snacks "should have a high potential for acceptance in the marketplace." |publisher=[[Center for Science in the Public Interest]] |date=February 13, 1997 |access-date=2007-07-07 |archive-date=2016-06-18 |archive-url=https://web.archive.org/web/20160618195225/http://www.cspinet.org/new/flaynal.html |url-status=dead }}</ref><ref name=NW>{{cite news |title=The Word Is 'Leakage'. Accidents may happen with a new OTC diet drug. |url=http://www.msnbc.msn.com/id/19263093/site/newsweek/ |quote=GlaxoSmithKline has a tip for people who decide to try Alli, the over-the-counter weight-loss drug it is launching with a multimillion-dollar advertising blitzβkeep an extra pair of pants handy. That's because Alli, a lower-dose version of the prescription drug [[Xenical]], could (cue the late-night talk-show hosts) make you soil your pants. But while Alli's most troublesome side effect, anal leakage, is sure to be good for a few laughs, millions of people who are desperate to take off weight may still decide the threat of an accident is worth it. |publisher=[[Newsweek]] |date=June 25, 2007 |access-date=2007-06-21 |url-status=dead |archive-url = https://web.archive.org/web/20070618160359/http://www.msnbc.msn.com/id/19263093/site/newsweek/ <!-- Bot retrieved archive --> |archive-date = 2007-06-18}}</ref> Vytorin (ezetimibe/simvastatin) tablets can cause steatorrhea in some people.<ref name=WP/><ref name=NW/> ===Excess whole nuts in diet=== Some studies have shown that stool lipids are increased when whole nuts are eaten, compared to nut butters, oils or flour<ref>{{cite journal |last1=Traoret |first1=C J |last2=Lokko |first2=P |last3=Cruz |first3=A C R F |last4=Oliveira |first4=C G |last5=Costa |first5=N M B |last6=Bressan |first6=J |last7=Alfenas |first7=R C G |last8=Mattes |first8=R D |year=2007 |title=Peanut digestion and energy balance |journal=International Journal of Obesity |volume=32 |issue=2 |pages=322β8 |doi=10.1038/sj.ijo.0803735 |pmid=17912269|doi-access= |url=http://www.locus.ufv.br/handle/123456789/23410 |url-access=subscription }}</ref> and that lipids from whole nuts are significantly less well absorbed.<ref>{{cite journal |last1=Hollis |first1=James |last2=Mattes |first2=Richard |year=2007 |title=Effect of chronic consumption of almonds on body weight in healthy humans |journal=British Journal of Nutrition |volume=98 |issue=3 |pages=651β6 |doi=10.1017/S0007114507734608 |pmid=17445351|doi-access=free }}</ref> ===Natural fats=== Consuming [[jojoba oil]] has been documented to cause steatorrhea and anal leakage because it is indigestible.<ref>{{cite journal |pmid=1415629 |year=1992|last1=Place|first1=A. R.|title=Comparative aspects of lipid digestion and absorption: Physiological correlates of wax ester digestion|journal=The American Journal of Physiology|volume=263|issue=3 Pt 2|pages=R464β71|doi=10.1152/ajpregu.1992.263.3.R464}}</ref> Consuming [[escolar]] and [[oilfish]] (sometimes mislabelled as [[Sablefish|butterfish]]) will often cause steatorrhea, also referred to as gempylotoxism or gempylid fish poisoning or [[keriorrhea]].<ref>[[Bad Bug Book]] - Foodborne Pathogenic Microorganisms and Natural Toxins Handbook: [https://web.archive.org/web/20090611062250/http://www.fda.gov/Food/FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePathogensNaturalToxins/BadBugBook/ucm071191.htm Gempylotoxin], [[Food and Drug Administration|FDA]]</ref> ===Artificial fats=== The fat substitute [[Olestra]], used to reduce digestible fat in some foods, was reported to cause leakage in some consumers during the test-marketing phase. As a result, the product was reformulated before general release to a hydrogenated form that is not liquid at physiologic temperature. The U.S. [[Food and Drug Administration]] warning indicated excessive consumption of Olestra could result in "loose stools"; however, this warning has not been required since 2003.<ref name=CSPI/><ref name=CSPI2>{{cite news |title=Reported medical side-effects of Olestra according to Procter and Gamble studies |url=http://www.cspinet.org/olestra/11cons.html |quote=Olestra sometimes causes underwear staining associated with "anal leakage." Olestra sometimes causes underwear staining. That phenomenon may be caused most commonly by greasy, hard-to-wipe-off fecal matter, but occasionally also from anal leakage (leakage of liquid olestra through the anal sphincter). |publisher=[[Center for Science in the Public Interest]] |access-date=2007-06-21 |url-status=dead |archive-url=https://web.archive.org/web/20070702223802/http://www.cspinet.org/olestra/11cons.html |archive-date=2007-07-02 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)